Related Experiment Video
Updated: Jun 4, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Can Systemic Sarcoidosis and Genetic Cardiomyopathy Coexist?
Anjali A Wagle1, Ria Gupta1, Maham Karatela1
1Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland, USA.
None:
Genetic cardiomyopathies and cardiac sarcoidosis share overlapping features, complicating diagnosis when both conditions coexist. We describe 3 patients with filamin C-associated, plakophilin-2-associated, and MYBPC3-associated cardiomyopathies who were later diagnosed with extracardiac sarcoidosis. Despite imaging findings concerning cardiac sarcoidosis, only 1 patient demonstrated active myocardial inflammation warranting immunosuppression; the others were managed as primary genetic cardiomyopathy. These cases illustrate the limited specificity of cardiac imaging in patients with known genetic cardiomyopathy and highlight the need for careful, individualized assessment to determine whether sarcoid inflammation contributes to arrhythmias or ventricular dysfunction.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
